NUREXONE BIOLOGIC INC (NRX.CA) Stock Analyst Earnings Estimates
TSX-V:NRX - TSX Venture Exchange - CA67059R1091 - Common Stock - Currency: CAD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A | |||||||||||
| EBITDA YoY % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | -5.535M | -3.624M 34.53% | N/A | N/A | N/A | |
| EBIT YoY % growth | -70K | -50K 28.57% | -30K 40.00% | -460K -1,433.33% | -110K 76.09% | -90K 18.18% | -60K 33.33% | -130K -116.67% | -5.541M -4,162.31% | -3.657M 34.00% | N/A -30.12% | N/A 213.48% | N/A | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A 11.11% | N/A | N/A -75.00% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.02 -37.33% | -0.02 -3.00% | -0.03 -50.00% | -0.01 48.50% | -0.02 | -0.04 -100.00% | -0.04 -33.33% | -0.03 -200.00% | -0.03 -50.00% |
| Revenue Q2Q % growth | |||||||||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | 1.35M 288.55% | -1.082M -17.55% | -1.133M 14.17% | -1.236M 3.81% | -1.442M -206.81% | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.02 23.08% | -0.03 | 0.01 | 35.28% |
| Q2 2024 Q2Q % growth | -3.00% | -0.02 | % | |
| Q1 2024 Q2Q % growth | -0.02 | -0.02 | 0.00 | 2.91% |
| Q4 2023 Q2Q % growth | -0.02 | -0.02 | 0.01 | 27.18% |
| Q3 2023 Q2Q % growth | -0.03 | -0.02 | -0.01 | -26.21% |
| Q2 2023 Q2Q % growth | -0.02 | -0.02 | 0.00 | 2.91% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 33.33% | 0% | 33.33% |
| Revenue | N/A | N/A | N/A | N/A |